Potential Morbidity Reduction With Proton Radiation Therapy for Breast Cancer.

Abstract:

:Proton radiotherapy confers significant dosimetric advantages in the treatment of malignancies that arise adjacent to critical radiosensitive structures. To date, these advantages have been most prominent in the treatment of pediatric and central nervous system malignancies, although emerging data support the use of protons among other anatomical sites in which radiotherapy plays an important role. With advances in the overall treatment paradigm for breast cancer, most patients with localized disease now exhibit long-term disease control and, consequently, may manifest the late toxicities of aggressive treatment. As a result, there is increasing emphasis on the mitigation of iatrogenic morbidity, with particular attention to heart and lung exposure in those receiving adjuvant radiotherapy. Indeed, recent landmark analyses have demonstrated an increase in significant cardiac events that is linked directly to low-dose radiation to the heart. Coupled with practice-changing trials that have expanded the indications for comprehensive regional nodal irradiation, there exists significant interest in employing novel technologies to mitigate cardiac dose while improving target volume coverage. Proton radiotherapy enjoys distinct physical advantages over photon-based approaches and, in appropriately selected patients, markedly improves both target coverage and normal tissue sparing. Here, we review the dosimetric evidence that underlies the putative benefits of proton radiotherapy, and further synthesize early clinical evidence that supports the efficacy and feasibility of proton radiation in breast cancer. Landmark, prospective randomized trials are underway and will ultimately define the role for protons in the treatment of this disease.

journal_name

Semin Radiat Oncol

authors

Braunstein LZ,Cahlon O

doi

10.1016/j.semradonc.2017.11.009

subject

Has Abstract

pub_date

2018-04-01 00:00:00

pages

138-149

issue

2

eissn

1053-4296

issn

1532-9461

pii

S1053-4296(17)30111-X

journal_volume

28

pub_type

杂志文章,评审
  • Adaptive management of cervical cancer radiotherapy.

    abstract::Since the breakthrough 10 years ago with concomitant radio-chemotherapy, substantial progress in the treatment of locally advanced cervical cancer has been lacking. Radiotherapy continues to be the cornerstone in the treatment of this disease and now shows much potential for progress, as image guidance of both externa...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2009.11.006

    authors: Tanderup K,Georg D,Pötter R,Kirisits C,Grau C,Lindegaard JC

    更新日期:2010-04-01 00:00:00

  • See, Think, and Act: Real-Time Adaptive Radiotherapy.

    abstract::The world is embracing the information age, with real-time data at hand to assist with many decisions. Similarly, in cancer radiotherapy we are inexorably moving toward using information in a smarter and faster fashion, to usher in the age of real-time adaptive radiotherapy. The three critical steps of real-time adapt...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1016/j.semradonc.2019.02.005

    authors: Keall P,Poulsen P,Booth JT

    更新日期:2019-07-01 00:00:00

  • Introduction.

    abstract::Copyright ...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1016/s1053-4296(98)80039-8

    authors: Dewhirst MW,Mitchell JB

    更新日期:1998-07-01 00:00:00

  • Lactate: mirror and motor of tumor malignancy.

    abstract::A number of studies have shown that malignant transformation is associated with an increase in glycolytic flux and in anaerobic and aerobic cellular lactate excretion. Using quantitative bioluminescence imaging in various primary carcinomas in patients (uterine cervix, head and neck, colorectal region) at first diagno...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2004.04.004

    authors: Walenta S,Mueller-Klieser WF

    更新日期:2004-07-01 00:00:00

  • Controversies in pathology in early-stage breast cancer.

    abstract::Breast-conserving therapy is a reliable, evidenced-based approach for early-stage breast carcinoma. This article reviews the issues and limitations related to simple margin measurements, data supporting the association between the amount of carcinoma near the margin, and ipsilateral breast failure risk. Additional fac...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2010.08.003

    authors: Goldstein SN

    更新日期:2011-01-01 00:00:00

  • Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.

    abstract::Historically, both adult and childhood Hodgkin lymphoma (HL) were treated with full-dose (35-45 Gy) extended-field radiation therapy (RT). Although this treatment was the first to produce reliable disease control, the resulting late toxicity led pediatric oncologists to pioneer the use of combined chemotherapy and low...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2007.02.009

    authors: Hodgson DC,Hudson MM,Constine LS

    更新日期:2007-07-01 00:00:00

  • Radiation therapy for benign disease of the orbit.

    abstract::Benign diseases of the orbit can cause significant impairment of visual function through direct effects on the eye or supporting orbital tissues. Persistent moderate-to-severe inflammatory symptoms, diplopia, and visual loss may prompt therapeutic intervention. Low doses of external-beam irradiation (20 Gy in 2-Gy fra...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/s1053-4296(99)80008-3

    authors: Smitt MC,Donaldson SS

    更新日期:1999-04-01 00:00:00

  • Radiosensitizers in hepatocellular carcinoma.

    abstract::Most hepatocellular carcinoma (HCC) patients present with locally advanced disease with a risk of development of intrahepatic or extrahepatic metastases. Conformal radiotherapy (RT) can be delivered to focal HCCs with sustained local control in selected HCC patients. However, it is frequently not possible to deliver t...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2011.05.008

    authors: Lee IJ,Seong J

    更新日期:2011-10-01 00:00:00

  • Big Data in Cancer Research: Real-World Resources for Precision Oncology to Improve Cancer Care Delivery.

    abstract::In oncology, the term "big data" broadly describes the rapid acquisition and generation of massive amounts of information, typically from population cancer registries, electronic health records, or large-scale genetic sequencing studies. The challenge of using big data in cancer research lies in interdisciplinary coll...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2019.05.002

    authors: Tsai CJ,Riaz N,Gomez SL

    更新日期:2019-10-01 00:00:00

  • Induction chemotherapy: to use or not to use? That is the question.

    abstract::The intensification of radiation, induction chemotherapy, and concomitant chemoradiotherapy has been extensively investigated over the past 2 decades for the nonsurgical management of locally advanced, nonmetastatic squamous cell head and neck cancer (HNC). Concurrent chemoradiation has emerged as the standard of care...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2008.09.003

    authors: Brizel DM,Vokes EE

    更新日期:2009-01-01 00:00:00

  • Spinal cord and peripheral nerve injury: current management and investigations.

    abstract::Treatment of patients having malignancy near or within the spinal cord can be more challenging or limited than in patients with brain tumors. This is largely because of the near total lack of noneloquent neural tissue associated with the spinal cord and/or intimately associated peripheral nerves. The adverse effects o...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/s1053-4296(03)00025-0

    authors: St Clair WH,Arnold SM,Sloan AE,Regine WF

    更新日期:2003-07-01 00:00:00

  • Androgen ablation in addition to radiation therapy for prostate cancer: is there true benefit?

    abstract::Prostate cancer patients may now be identified as having a high risk of failing single-modality treatment based on pretreatment prostate specific antigen (PSA), Gleason score, and palpable stage. In particular, a PSA greater than 20 ng/mL portends a biochemical failure rate of 50% to 80% when radiation therapy, surger...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/s1053-4296(98)80005-2

    authors: Pollack A,Zagars GK

    更新日期:1998-04-01 00:00:00

  • The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.

    abstract::The linear-quadratic (LQ) model is widely used to model the effect of total dose and dose per fraction in conventionally fractionated radiotherapy. Much of the data used to generate the model are obtained in vitro at doses well below those used in radiosurgery. Clinically, the LQ model often underestimates tumor contr...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1016/j.semradonc.2008.04.005

    authors: Kirkpatrick JP,Meyer JJ,Marks LB

    更新日期:2008-10-01 00:00:00

  • Controversies in clinical trials in proton radiotherapy: the present and the future.

    abstract::Proponents of proton radiotherapy have cited the dose distribution characteristics of proton beams as evidence of its superiority over photon radiotherapy. Outcomes after photon radiotherapy remain suboptimal owing to poor local control and normal-tissue toxicity in many clinical indications. Critics of proton radioth...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1016/j.semradonc.2012.11.004

    authors: Miller RC,Lodge M,Murad MH,Jones B

    更新日期:2013-04-01 00:00:00

  • Current management for late normal tissue injury: radiation-induced fibrosis and necrosis.

    abstract::Radiation-induced fibrosis (RIF) and radionecrosis (RN) are late complications that are usually considered irreversible. Usual management strategy includes eliminating local and general aggravating factors and controlling acute and chronic inflammation with steroids. Thanks to progress in understanding the pathophysio...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2006.11.006

    authors: Delanian S,Lefaix JL

    更新日期:2007-04-01 00:00:00

  • The physical parameters and molecular events associated with radiation-induced lung toxicity.

    abstract::Radiation therapy (RT) is frequently used to treat patients with tumors in and around the thorax. Clinical radiation pneumonitis is a common side effect, occurring in 5% to 20% of patients. Efforts to identify patients at risk for pneumonitis have focused on physical factors, such as dose and volume. Recently, the und...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2000.9424

    authors: Vujaskovic Z,Marks LB,Anscher MS

    更新日期:2000-10-01 00:00:00

  • Fractionation and outcomes with palliative radiation therapy.

    abstract::A dose-response relationship can be established for local control of a variety of malignancies treated with radiation, yet palliation of symptoms oftentimes does not have a clear dose-response relationship. It is important that palliation be achieved with as efficient a fractionation schedule as possible in patients w...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2000.6595

    authors: Anderson PR,Coia LR

    更新日期:2000-07-01 00:00:00

  • Postmastectomy radiotherapy: future directions.

    abstract::With careful interpretation of existing studies of postmastectomy radiotherapy, much has been learned about the ability of radiotherapy to significantly reduce local failure and potentially impact on survival. With this knowledge, however, has come additional questions about the mechanisms by which radiotherapy could ...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/s1053-4296(99)80023-x

    authors: Pierce LJ

    更新日期:1999-07-01 00:00:00

  • Radiation and inflammation.

    abstract::The immune system has the power to modulate the expression of radiation-induced normal and tumor tissue damage. On the one hand, it can contribute to cancer cure, and on the other hand, it can influence acute and late radiation side effects, which in many ways resemble acute and chronic inflammatory disease states. Th...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2014.07.007

    authors: Schaue D,Micewicz ED,Ratikan JA,Xie MW,Cheng G,McBride WH

    更新日期:2015-01-01 00:00:00

  • Sphincter preservation in rectal cancer. Local excision followed by postoperative radiation therapy.

    abstract::The management of distal rectal cancer is in evolution. Although abdominoperineal resection has been long regarded as the definitive treatment of distal rectal cancer, it is associated with significant morbidity--loss of anorectal function with a permanent colostomy and a high incidence of sexual and genitourinary dys...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/s1053-4296(98)80033-7

    authors: Willett CG

    更新日期:1998-01-01 00:00:00

  • Measuring the quality of care in radiation oncology.

    abstract::Quality care is one of the dominant issues in health care today. In this article, we will review the key concepts underlying quality measures and discuss how measures are developed and defined. We will next examine how these measures are currently being used and will conclude with some thoughts regarding the steps nec...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2008.01.008

    authors: Hayman JA

    更新日期:2008-07-01 00:00:00

  • Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?

    abstract::Targeting specific biological pathways in tumor development has been heralded as a promising approach to the treatment of cancer. Familiar to most investigators are the studies done with epidermal growth factor receptor (EGFR) antagonists, but newer agents currently under development also target angiogenic or cell cyc...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/j.semradonc.2003.12.009

    authors: Raben D,Bianco C,Milas L,Ang KK

    更新日期:2004-04-01 00:00:00

  • Inflammatory breast cancer.

    abstract::Inflammatory breast cancer (IBC) represents the most virulent form of breast cancer, characterized by involvement of the skin and rapid progression of the disease. Management involves careful coordination of all multidisciplinary modalities, including imaging, systemic chemotherapy, surgery, and radiation therapy. The...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2009.05.008

    authors: Woodward WA,Cristofanilli M

    更新日期:2009-10-01 00:00:00

  • Sequential Therapy in the Treatment of Locally Advanced Noninflammatory Breast Cancer.

    abstract::Optimal care of patients with locally advanced breast cancer requires the use and thoughtful integration of all effective modalities of treatment. A number of alternative combinations of surgery, chemotherapy, and radiation have been promoted, each with its own particular advantages and shortcomings. The advantages of...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO00400217

    authors: Strom EA,Dhingra K

    更新日期:1994-10-01 00:00:00

  • Utilization of intensity-modulated radiation therapy and image-guided radiation therapy in pancreatic cancer: is it beneficial?

    abstract::The recent development of intensity-modulated radiation therapy (IMRT) and improvements in image-guided radiotherapy (IGRT) have provided considerable advances in the utilization of radiation therapy (RT) for the management of pancreatic cancer. IGRT allows for the reduction of treatment volumes, potentially less chan...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semradonc.2013.11.003

    authors: Reese AS,Lu W,Regine WF

    更新日期:2014-04-01 00:00:00

  • Gynecologic brachytherapy I: Proper incorporation of brachytherapy into the current multimodality management of carcinoma of the cervix.

    abstract::The incidence of carcinoma of the cervix has continuously declined over the past decades because of effective screening. The International Federation of Gynecology and Obstetrics (FIGO) clinical staging, though universally used, is considered inadequate either to determine the type of treatment or to predict treatment...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2002.28664

    authors: Nori D,Dasari N,Allbright RM

    更新日期:2002-01-01 00:00:00

  • The Physics of Radiosurgery.

    abstract::Stereotactic radiosurgery was introduced more than 40 years ago as a way of treating various intracranial lesions without recourse to open-skull surgery. Since then, it has been extended both in terms of the radiation modalities that have been used and the types of lesions treated. Each radiation modality has its own ...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1054/SRAO00500175

    authors: Verhey LJ,Smith V V

    更新日期:1995-07-01 00:00:00

  • Functional imaging of normal tissues with nuclear medicine: applications in radiotherapy.

    abstract::Functional imaging techniques are gaining significant interest from radiation oncologists. Many now claim the need for physical and physiological information during both treatment planning and in the study of normal tissue injury. Toward this goal, the nuclear medicine functional imaging modalities, single-photon emis...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章,评审

    doi:10.1053/srao.2001.18101

    authors: Munley MT,Marks LB,Hardenbergh PH,Bentel GC

    更新日期:2001-01-01 00:00:00

  • Clinical Results of the Combination of Radiation and Fluoropyrimidines in the Treatment of Intrahepatic Cancer.

    abstract::Radiation therapy has played a minor role in the conventional management of patients with unresectable primary hepatobiliary malignancies and liver metastases. This can be attributed to normal tissue toxicity, which has limited the dose of radiation that can be safely administered, and imaging limitations, which have ...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO00700313

    authors: McGinn CJ,Lawrence TS

    更新日期:1997-10-01 00:00:00

  • Chemotherapy for Stage IV Non-Small Cell Lung Cancer: Protocol Versus Nonprotocol? Is Noninvestigational Treatment Worthwhile? Patient Selection? Which Regimen? What's Next?

    abstract::The results of selected chemotherapy trials and philosophical considerations regarding the role of chemotherapy in Non-Small Cell Lung Cancer are discussed in this review. The issue of treating patients within a clinical or with a "standard regimen" is addressed. In addition, the survival results of randomized trials ...

    journal_title:Seminars in radiation oncology

    pub_type: 杂志文章

    doi:10.1053/SRAO00600110

    authors: Bonomi P

    更新日期:1996-04-01 00:00:00